SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-08-033568
Filing Date
2008-05-28
Accepted
2008-05-28 19:39:21
Documents
1
Period of Report
2008-05-27

Document Format Files

Seq Description Document Type Size
1 MAIN DOCUMENT DESCRIPTION bdn56845_bdn4adf.html 4  
1 MAIN DOCUMENT DESCRIPTION bdn56845_bdn4adf.xml 4 3952
  Complete submission text file 0001209191-08-033568.txt   5701
Mailing Address
Business Address 8271 154TH AVENUE NE REDMOND WA 98052
FRAZIER ALAN D (Reporting) CIK: 0001018534 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-51820 | Film No.: 08864714

Mailing Address 2091 STIERLIN COURT MOUNTAIN VIEW CA 94043
Business Address 2091 STIERLIN COURT MOUNTAIN VIEW CA 94043 650.944.7000
Alexza Pharmaceuticals Inc. (Issuer) CIK: 0001344413 (see all company filings)

IRS No.: 770567768 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1